Get startedLog in
    Picture of Nugenerex Immuno-Oncology logo

    NUGX — Nugenerex Immuno-Oncology Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Nugenerex Immuno-Oncology, fiscal year end - July 31st, USD millions except per share, conversion factor applied.

    2018
    July 31st
    2019
    July 31st
    2020
    July 31st
    Period Length:12 M12 M12 M
    Source:PROSPECTUSPROSPECTUS10-K
    Standards:
    USG
    USG
    USG
    Status:FinalFinalFinal
    Net Income/Starting Line-0.173-1.11-1.59
    Non-Cash Items0.5980.7150.855
    Other Non-Cash Items
    Changes in Working Capital-0.4240.3920.733
    Change in Payable / Accrued Expenses
    Cash from Operating Activities0.001-0.001-0
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.001-0.001-0